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Abstract
Purpose Knowledge about the localization and outcome
of iatrogenic dissection (ID) during endovascular treatment
of acute ischemic stroke (AIS) is limited. We aimed to
determine the frequency, clinical aspects and morphology of
ID in endovascular AIS treatment and to identify predictors
of this complication.
Methods Digital subtraction angiography (DSA) of ID car-
ried out during endovascular treatment between January
2000 and March 2012 have been re-evaluated. The ID lo-
calization and morphology were analyzed and related to the
interventional techniques. Baseline clinical and radiological
findings, treatment modality and outcome were compared
with patients without ID.
Results Out of 866 patients 18 (2%) suffered an ID (44%
female, median age 64 years). Localization was extracra-
nial in 15 (83%, 14 internal carotid artery and 1 vertebral
artery) and intracranial in 3 (17%; 1 vertebrobasilar dissec-
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tion and 2 in the anterior circulation). Of the IDs 5 (28%)
resulted in a high-degree, 3 (17%) in a moderate, 5 (28%)
in a mild and 5 (28%) in no stenosis and 8 IDs were stented
in the acute phase. At 3 months 7 (42%) patients had a fa-
vorable outcome (modified Rankin score mRS  2) and 6
(33%) patients had died. Patients with ID had a different
stroke etiology (p = 0.041), were more likely to be smokers
(44% versus 19%, p = 0.015) and were more likely to be
treated with mechanical thrombectomy (100% versus 60%,
p < 0.001). Although two ID patients had relevant compli-
cations, the outcome did not differ between the groups.
Conclusion The occurrence of ID is a rare complication of
endovascular AIS treatment associated with smoking and
mechanical thrombectomy.
Keywords Iatrogenic · Dissection · Endovascular
treatment · Ischemic stroke · Interventional neuroradiology
Introduction
Acute arterial ischemic stroke (AIS) is one of the leading
causes of mortality and morbidity worldwide [1, 2]. Im-
mediate and efficacious revascularization of the occluded
vessel is crucial to improve outcome [3, 4]. Over the past
decade endovascular management of AIS has rapidly im-
proved and several catheter-based treatment systems have
been developed. To date, 5 randomized controlled trials
have shown that endovascular clot retrieval in addition to
best medical treatment with or without intravenous recom-
binant tissue plasminogen activator (rtPA) improves out-
come in patients with stroke occurring in the anterior circu-
lation with proximal vessel occlusion [5–9]; however, de-
spite minimally invasive device systems, endovascular pro-
cedures still carry a risk of iatrogenic complications, poten-
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tially worsening the outcome. Manipulation of the catheter,
guidewire or thrombectomy devices could cause vessel wall
injury. Studies reporting ID rates during cerebral angiogra-
phy mainly include diagnostic angiography only [10–12] or
interventional angiography for indications other than AIS,
often in an elective, non-urgent setting [13–15]. Only a few
studies have reported complication rates in endovascular
AIS treatment (ranging from 1.7% to 3.9%), but clinical
characteristics, risk factors, outcomes and morphological
descriptions are lacking [5, 9, 16, 17]. We aimed to assess
the localization and morphology of ID, the clinical char-
acteristics and risk factors for ID and outcomes in patients
suffering from ID.
Methods
Our study is based on the Bernese stroke registry, a prospec-
tive database on patients with AIS [18–20]. Baseline and
3-month outcome data on consecutive AIS patients admitted
to the Neurological Department of the University Hospital
of Bern are collected. For this study, we reviewed clini-
cal and imaging data on all AIS patients aged ≥16 years
who underwent endovascular AIS treatment between Jan-
uary 2000 and March 2012. All images of confirmed or
assumed IDs were retrieved from our PACS (picture archiv-
ing and communicating system) and the digital subtraction
angiography (DSA) series were carefully re-evaluated for
this study. An ID was defined as the presence of any of the
following signs on DSA: intimal flap, fusiform or irregular
aneurysmal dilation at a non-bifurcation site, double lumen
or a string-and-bead sign, or if signs of a wall hematoma
were present on fat-saturated T1-weighted magnetic reso-
nance imaging (MRI).
Baseline clinical data, such as age, sex, pre-stroke score
on the modified Rankin scale (mRS), vascular risk factors,
National Institutes of Health Stroke score (NIHSS) on ad-
mission, and stroke etiology according to the Trial of Org
10172 in Acute Stroke Treatment (TOAST) classification
[21] were collected. Imaging data, such as vessel occlusion
site and grade of occlusion, were assessed at baseline, and
after endovascular treatment. Furthermore, imaging in ID
cases was reviewed for ID characteristics on DSA, such as
localization and stenosis caused by an ID in the acute phase
DSA and recanalization on follow-up imaging by magnetic
resonance angiography (MRA) or computed tomography
angiography (CTA). Stenosis caused by an ID was defined
as high grade if ≥80% of the vessel lumen was obstructed,
moderate for 50–79%, and mild for <50% local degree of
stenosis. The length of the stenosis was classified as either
short (1 cm) or long (>1 cm).
Follow-up imaging was performed in all patients be-
tween 12 and 24 h after the intervention or sooner in the
case of any clinical deterioration. The remaining local arte-
rial constriction was graded according to the thrombolysis
in myocardial ischemia (TIMI) classification [22]. All in-
terventions were performed in our 24-h/7-day stroke unit
by 5 fully trained and experienced neurointerventionalists
in accordance with institutional guidelines. Endovascular
treatment was based on a diagnostic transfemoral 4-ves-
sel DSA and consisted of (1) mechanical thrombectomy
(MT), (2) local intra-arterial thrombolysis using urokinase,
(3) combined intra-arterial lysis with urokinase and sys-
temic intravenous thrombolysis using rtPA or (4) by a com-
bination of MT and pharmacological thrombolysis. Un-
til the introduction of stent retriever technology in 2010,
MT was performed by aspiration via a 5 French aspira-
tion catheter (Tracker 35, Boston Scientific; VASCO-ASP,
BALT [Montmorency, France]), percutaneous transluminal
angioplasty (PTA), stenting or gentle mechanical disrup-
tion of the thrombus in combination with local injection of
urokinase into the thrombus for up to 2 h. The Merci device
(Concentric Medical, Mountain View, California, USA) has
not been used. Based on the localization, grade of stenosis
and hemodynamic relevance of the lesion, the responsible
interventional neuroradiologist and neurologist decided on
endovascular treatment of ID. Clinical outcome at 3 months
was assessed using the mRS, with favorable outcome de-
fined as a mRS score  2.
Statistics
Statistical analyses were performed using the SPSS©-soft-
ware version 21. Pearson’s χ2-test or Fisher’s exact test
(nominal variables) and Mann-Whitney U-test (ordinal,
continuous variables) were used for group comparison of
patients with and without ID. A 2-sided probability value
p < 0.05 was considered statistically significant.
Results
Out of 869 consecutive AIS patients who underwent an
acute endovascular stroke intervention, 866 were included
in this study with a median age of 68 years (interquartile
range IQR 57–76 years) and 385 (45%) women. Of the
patients three had to be excluded from the study because
the intervention was not documented in our PACS system.
Iatrogenic Arterial Dissection
18 patients (2%) suffered from ID during the endovascu-
lar procedure. No patient developed multiple IDs. Clinical
and radiological characteristics are summarized in Table 1
and 2.
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15 patients (83% of all IDs) suffered an extracranial
ID of which 14 were located in the internal carotid artery
(ICA) and 1 in the vertebral artery (VA). The VA dissec-
tion was a small, hemodynamically irrelevant intimal flap
during passage of the C1-loop of the dominant VA with the
5-French aspiration catheter. Of the patients 3 (17%) had
an intracranial ID, located at the vertebrobasilar junction
(Fig. 1), in the distal ICA, and in the middle cerebral artery
(M1 branch).
The ID was long in 7 (39%) and short in 11 patients
(61%). The stenosis caused by the ID was high grade in 5
(28%), moderate in 3 (17%), and mild in 5 (28%) cases; the
remaining 5 (28%) IDs did not result in stenosis. No oc-
clusive ID was observed. Recanalization of ICA occlusion
(tandem and carotid-T occlusions) was the most frequent
reason for dissections (12 out of 16 in the anterior circu-
lation). Movement of the patient during navigation through
the occluded ICA and coiling or kinking of the cervical seg-
ment of the ICA most likely caused the IDs in 9 patients.
Acute management of the ID by stent placement was per-
formed in 8 patients (44%). All 5 patients with high-grade
stenosis were treated as well as 1 patient with moderate,
1 with mild stenosis and 1 patient without stenosis. None
of the ID patients showed clinical signs clearly attributable
to the ID in the short-term follow-up and new additional
ischemic or hemorrhagic lesions were not detected on CT
or MRI 12–24 h after endovascular treatment. At 3-month
follow-up, 7 patients had a favorable outcome (mRS  2)
and 6 had died, of which 4 patients died as a result of the
AIS as a malignant middle cerebral artery (MCA) infarction
or extensive brainstem infarction due to basilar artery (BA)
occlusion, without any further signs of ID-related compli-
cations. The other 2 patients died from AIS complications,
possibly related to the ID as described.
Patient 4 had an extended stroke affecting the cerebel-
lum bilaterally and right thalamus and underwent PTA of
a proximal BA stenosis. The vertebrobasilar dissection be-
came visible after aspiration of the occluding thrombus and
was treated by implantation of a short stent (Fig. 1). The
12–24 h follow-up MRA revealed a contrast defect at the
site of the stent, either caused by an in-stent occlusion or
an artefact and 3 days after the initial event, the patient
suffered recurrent AIS with new pontine lesions leading to
death 1 day later.
Patient 12 had an intracranial MCA-M1 ID after AIS
due to a carotid-T occlusion and died 12 days later of an
intracranial hemorrhage. The M1 ID was not treated with
a stent because the risk of acute endovascular treatment was
estimated to be high in a patient with systemic lupus erythe-
matosus under oral corticosteroid treatment. She had been
treated with aspirin since the 12–24 h follow-up MRI and
MRA showed a complete recanalization of the occluded
K
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Table 2 Comparison of patients with and without Iatrogenic Dissection (ID), following endovascular treatment of acute ischemic stroke
Variable Valid n
(total n = 866)
ID (n = 18) No ID (n = 848) 2-sided p
Age (years), median (IQR) 866 64 (56–77) 68 (58–76) 0.608
Female 866 8 (44%) 377 (45%) 1.000
Pre-AIS mRS  2 865 17 (94%) 832 (98%) 0.288
NIHSS, median (IQR) 864 15 (12–19) 15 (10–20) 0.974
Vascular risk factors
– Diabetes mellitus 864 5 (28%) 120 (14%) 0.163
– Arterial hypertension 864 12 (67%) 521 (62%) 0.808
– Hypercholesterolemia 866 8 (44%) 453 (52%) 0.635
– Current smoking 851 8 (44%) 161 (19%) 0.015
– Past smoking (5 years) 851 0 104 (13%) 0.151
– Coronary heart disease 862 1 (6%) 161 (19%) 0.222
– Atrial fibrillation 787 5 (33%) 288 (37%) 1.000
– Previous ischemic cerebrovascular
event
866 2 (11%) 133 (16%) 1.000
– Family history: stroke 637 2 (22%) 106 (17%) 0.854
sCAD as AIS etiology 866 2 (11%) 33 (4%) 0.162
Time from symptom onset to interven-
tion (min), median (IQR)
858 272 (228–378) 273 (220–345) 0.566
Mechanical thrombectomy 866 18 (100%) 506 (60%) <0.001
3-month follow-up
Favorable outcome (mRS  2) 837 7 (39%) 349 (43%) 0.814
Mortality 837 6 (33%) 198 (24%) 0.405
IQR interquartile range, AIS acute ischemic stroke, mRS modified Ranking scale, sCAD spontaneous cervical artery dissection
intracranial ICA and no hemorrhagic or new ischemic le-
sions.
Comparison of AIS Patients with and without ID
Most of the clinical and radiological baseline variables in
AIS patients treated endovascularly with and without ID did
not differ significantly (Table 2). Stroke etiology and per-
centage of active smokers differed, with ID patients having
a cardioembolic etiology less often but an undetermined
AIS etiology more often (supplementary Fig. 1) and more
often being smokers. Patients with ID were more likely to
have been treated with MT than AIS patients without ID.
All ID occurred in patients who had undergone MT. Clinical
data at 3-month follow-up were available for all ID and for
819 (97%) of the non-ID patients. Outcome did not differ,
either in the distribution of the mRS scores (supplementary
Fig. 2) or when dichotomized (p = 0.814) or comparing
mortality (p = 0.405).
Discussion
The results of our study indicate that the risk for ID in AIS
patients undergoing endovascular treatment is low. Mechan-
ical thrombectomy and smoking status are associated with
a higher risk for ID. The ID did not have a significant im-
pact on clinical outcome compared to patients without ID
despite severe complications possibly related to ID in 2 pa-
tients. To date, arterial dissection as a complication of en-
dovascular AIS treatment has been systematically reported
by the MR CLEAN, REVASCAT, SWIFT and STAR inves-
tigators [5, 9, 16, 17]. Dissection occurred in 1% of STAR
patients and 3.9% of REVASCAT patients as a complication
of AIS treatment with either Solitaire® (Medtronic, Dublin,
Ireland) flow restoration thrombectomy or combined with
medical management alone [9, 17]. The MR CLEAN trial
found a procedure-related dissection in 1.7% and vessel
perforation in 0.9% of patients who received intra-arterial
treatment, but provided no detailed information on the type
of treatment administered (e.g. intra-arterial thrombolysis,
MT or both) [5]. In the SWIFT trial, ID was observed in
5 (3.5%) of the 144 patients treated with MT (Merci® and
Solitaire® devices) [16]. These numbers are in line with the
ID frequency of 2% (18/866) overall and 3.4% (18/524)
seen in MT patients in our study. One of the IDs occur-
ring in SWIFT was adjudicated to be a serious adverse
event; however, detailed information on clinical and radio-
logical characteristics and outcome of patients with ID are
lacking in all of the abovementioned studies. In a study on
interventional cerebral angiographies with indications other
than AIS, ID occurred in 0.26–0.7% of patients, all being
K
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Fig. 1 DSA of patient 4, a 64-year-old man with ID at the verte-
brobasilar junction. a Left VA injection shows the occlusion of the
proximal basilar artery with the tip of the microcatheter in the thrombus
(arrow) during application of urokinase. b The underlying high-grade
stenosis becomes visible after successful local intra-arterial thrombol-
ysis and was treated by PTA. c The dissection following PTA is clearly
visible on the DSA in lateral projection (arrow). d Stabilization of the
dissection by insertion of a small self-expanding stent (arrows)
asymptomatic [13, 15]. In purely diagnostic cerebral an-
giography, ID occurred in 0–0.4% of patients, and again all
were described as being asymptomatic [10–13].
In this study 12 out of 16 dissections in the anterior
circulation occurred during recanalization of a former oc-
cluded ICA. The fact that this occlusion location is the most
difficult to recanalyze, has to be performed without imag-
ing-guided navigation, normally needs the most passes and
largest catheters and devices presumably leads to a higher
number of IDs in these patients. Moreover, movement of the
patient during or after passage of the carotid occlusion was
observed in 9 patients (see selected case Fig. 2). It is well
known that turning the head and neck changes the shape
and curves of the carotid arteries and the turning the head
maneuver has been a valuable technique in interventional
neuroradiology for many years if passage of a constricted
ICA is difficult.
Elongation of the ICA, especially in combination with
kinking and coiling, which has been shown to be asso-
Fig. 2 DSA of patient 1, a 64-year-old man with an ICA/MCA tan-
dem occlusion. a The stump of the occluded ICA can be identified in
the lateral projection of the DSA (arrow). b Frozen image of the DSA
series performed via the aspiration catheter, which has passed the site
of occlusion. The original shape of the ICA is subtracted and outlined
as white shadow behind the dark course of the ICA after ipsilateral turn
of the head. The site of the dissection is clearly visible as a buttonhole
stenosis (arrow). c, d The site and extension of the dissection (arrows)
become visible after initiation of general anesthesia and thrombus as-
piration through the 8 F guiding catheter with its tip distal from the site
of occlusion
ciated with carotid dissections [23], became visible after
recanalization of the ICA in 10 of the 16 IDs in the anterior
circulation. Considering that the damage to the vessel wall
is invisible until successful recanalization of the artery, we
cannot establish the exact time and reason for the dissection
in all our patients; however, in our experience of more than
200 carotid artery revascularizations in the setting of AIS
[24], damage to the wall can happen during the passage of
the wire, transit of the catheter (Fig. 3), PTA, stent place-
ment or retrieval of instruments used to recanalize the distal
tandem occlusion. Stent placement, the last step in tandem
occlusion recanalization using the upside-down technique
[25], was the most likely reason for carotid dissection in
2 patients. The occluded ICA appeared to be straight with
the wire or distal protection material in place, but returned
to the original shape with kinking or narrow looping after
removal of the aspiration or distal access catheter (Fig. 4).
The linear stretching of the proximal ICA segment by the
stent may aggravate the kinking at the distal end of the
K
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Fig. 3 Patient 8, 79-year-old man with tandem occlusion of the internal carotid and middle cerebral arteries. a DSA of the right common carotid
artery in lateral projection shows the pseudo-occlusion of the ICA and absence of collaterals from the branches of the external to the internal carotid
artery (ECA-ICA collaterals), a typical sign of acute ICA occlusion. b The anterior-posterior (a.p.) view shows the tip of the 5 F aspiration catheter
in front of the occluding M1 thrombus. The coiling of the ICA was passed without wire and without any problems. c Control DSA following
recanalization of the ICA and MCA confirms two small, hemodynamically irrelevant dissections (arrows) of the proximal and distal segments of
the looping of the distal cervical segment of the ICA
Fig. 4 Patient 9: 79-year-old woman with right ICA/M1 tandem occlusion. a The stump of the occluded ICA is well outlined in the a. p. projection
of the DSA. b Anterior-posterior roadmap with the wire in the lumen of the occluded ICA pretends a straight course up to the petrous part. c Change
of the course of the ICA following exchange of the stiff wire and placement of a filter wire (fine arrows) with a soft wire tip, which allows the ICA
to reshape with a kinking below the skull base (bold arrow). d Dissection following stent placement extending into the now proximally kinked
cervical segment of the ICA, which was treated with a second more flexible stent
stent, resulting in a dissection, which was treated in our
2 cases by insertion of a second, more flexible stent.
All patients with an ID-related high-grade stenosis and
3 patients with a stenosis of <80% were treated with a stent,
achieving TIMI 2–3 recanalization in all but one. Stent
placement in initially low-grade stenosis was performed
only if control DSA indicated progression of the dissec-
tion. During the waiting period of 15–30 min, a microwire
with the tip in the true lumen distal to the ID secured rapid
access and stenting in the case of an increase of the false
lumen and subsequent complete occlusion of the artery.
Similarly, therapy in the five SWIFT ID patients consisted
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of conservative management in three, and stent placement
and balloon angioplasty in one each [16]. The rationale for
choosing the different treatment modes, recanalization rates
and patient outcomes was not reported.
In our study, patients with ID were significantly more
often smokers compared to patients without ID. Smoking
has not been described as a risk factor for spontaneous
cervicocerebral artery dissection [26]; however, in patients
with spontaneous VA dissection, smokers had cerebral is-
chemia more often than non-smokers [27]. In smokers en-
dothelial function is impaired, the coagulation cascade is
activated, and inflammatory cytokines are upregulated [28].
Thus, an increased vulnerability of the arterial wall to me-
chanical injuries in smokers is possible. Patients with ID
had different AIS etiologies than patients without ID. Car-
dioembolic strokes were less frequent in ID patients. We
hypothesize that a cardioembolic occlusion of a previously
normal artery may be easier to reopen than in other sub-
types of stroke. Cervicocerebral arterial dissection carries
the risk for serious complications, such as cerebral ischemia
or subarachnoid hemorrhage. Comparing clinical outcome
and mortality in the endovascularly treated AIS patients in-
cluded in this study, patients with ID did not significantly
differ from patients without ID. Nevertheless, two patients
died as a result of AIS complications possibly related to the
ID, indicating that ID is a clinically relevant complication of
endovascular treatment with mechanical devices; therefore,
endovascular treatment for AIS should only be performed
in institutions where such complications can be managed
by staff experienced in weighing the risks and benefits of
this intervention and skilled in how to manage ID.
This study is mainly limited by the single center de-
sign and the retrospective identification of ID cases based
on the initial report of the interventional neuroradiologist;
however, the DSA series are stored in full length in our PAC
System, and two senior interventional neuroradiologists in-
dependently reviewed the DSAs of all ID patients. Another
limitation may be that different endovascular recanalization
techniques and devices have been used since the start of this
study in 2000. On the other hand, by comparing those dif-
ferent techniques it became evident that most IDs occur
during gaining access to the thrombus, especially if an oc-
cluded, torturous internal carotid artery has to be passed
without biplane roadmap navigation. Surprisingly, no ID
was observed during withdrawal of a stent retriever.
This study does not allow conclusions to be drawn on
how to best treat an ID. Taking into account the benign
course of IDs in most patients, “watchful waiting” seems
justified prior to stent implantation.
In conclusion, ID is rare in endovascular treatment of
acute ischemic stroke; however, a high index of suspicion
for ID is key to its detection during the endovascular in-
tervention, to immediately provide appropriate treatment,
for instance in case of progression, and thus increase the
chances of a good outcome.
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